RecallRadar

FDA Device recall Z-2100-2017

Mobius3D Product Usage: Mobius3D software is used for quality assurance and treatment plan verification in radiation therapy

On 2017-05-24 the FDA classified a Class II recall of Mobius3D Product Usage: Mobius3D software is used for quality assurance and treatment plan verification in radiation therapy by Mobius Medical Systems, citing mobius3D version 1.5.0 contained a defect in software code which affects users who perform beam customization, and may lead to a discrepancy in dose calculation between this versi….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2100-2017
ClassificationClass II
Statusterminated
Initiated2015-02-23
Published2017-05-24
Last updated2026-09-13 11:54 UTC
CompanyMobius Medical Systems
DistributionUS

Product

Mobius3D Product Usage: Mobius3D software is used for quality assurance and treatment plan verification in radiation therapy. It calculates radiation dose three-dimensionally in a representation of a patient or a phantom. The calculation is based on read-in treatment plans that are initially calculated by a treatment planning system, and may additionally be based on external measurements of radiation fields from other sources such as linac delivery log data. Mobius3D is not a treatment planning system. It is only to be used by trained radiation oncology personnel as a quality assurance tool.

Reason

Mobius3D version 1.5.0 contained a defect in software code which affects users who perform beam customization, and may lead to a discrepancy in dose calculation between this version of Mobius3D (1.5.0) and the prior version (1.4.2), where none should have been expected.

Identifiers

code_infoVersion 1.5.0 and 1.5.2 of the Mobius3D software is affected.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2100-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.